DCF — MARSHFIELD MEDICAL CENTER WESTON
Enterprise Value: $-532.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-532.3M
Enterprise Value
$-163.9M
PV of Cash Flows
$-368.4M
PV of Terminal Value
$-593.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $198.3M | $-35.6M | -18.0% | $-44.0M | $-40.0M |
| Year 2 | $204.2M | $-34.7M | -17.0% | $-43.3M | $-35.8M |
| Year 3 | $210.4M | $-33.6M | -16.0% | $-42.5M | $-31.9M |
| Year 4 | $216.7M | $-33.5M | -15.0% | $-42.7M | $-29.2M |
| Year 5 | $223.2M | $-34.0M | -15.0% | $-43.4M | $-27.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-532.3M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$192.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.1847052586402977
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5